Pacific released a research report on April 18 stating that it gave Capital Securities (601136.SH) an increase in holdings rating. The main reasons for the rating include: 1) excellent fixed income performance driven a sharp increase in investment busines
Zhitong FinanceApr 18 09:02
Capital Securities (601136): Net revenue and profit increased, and the investment business performed well
太平洋證券Apr 17 00:00
Capital Securities (601136): Self-operated business flexibility and other business resilience highlighted
太平洋證券Nov 5, 2023 00:00
Capital Securities (601136): Continuously consolidating advantages, business development path is progressing steadily
太平洋證券Aug 31, 2023 00:00
Capital Securities (601136) 23Q1 review: Proprietary income rebounded sharply, net asset management income declined
太平洋證券May 25, 2023 00:00
First coverage of Capital Securities (601136): steady development of fixed income business, rise of asset management drives performance
太平洋證券Apr 26, 2023 00:00
Catalyst Biosciences (CBIO) Gets a Buy From LifeSci Capital
TipRanksDec 28, 2022 05:00
Gesher I Corp (GIAC) Receives a New Rating From Chardan Capital
TipRanksDec 27, 2022 20:30
Chardan Capital Initiates Coverage On Century Therapeutics With Buy Rating, Announces Price Target of $19
Benzinga Real-time NewsDec 27, 2022 18:46
Chardan Capital Initiates Coverage On Gesher I Acquisition With Buy Rating, Announces Price Target of $13
Benzinga Real-time NewsDec 27, 2022 18:46
CarMax (KMX) Gets a Buy From RBC Capital
TipRanksDec 27, 2022 09:50
RBC Capital Remains a Buy on Citizens Financial (CFG)
TipRanksDec 24, 2022 09:50
RBC Capital Keeps Their Buy Rating on Spirit AeroSystems (SPR)
TipRanksDec 24, 2022 09:50
Silgan Holdings (SLGN) Gets a Buy From RBC Capital
TipRanksDec 24, 2022 09:50
Ardagh Metal Packaging (AMBP) Receives a Hold From RBC Capital
TipRanksDec 24, 2022 09:50
RBC Capital Sticks to Its Buy Rating for Xylem (XYL)
TipRanksDec 24, 2022 09:50
RBC Capital Sticks to Its Hold Rating for CareTrust REIT (CTRE)
TipRanksDec 24, 2022 09:50
KeyCorp (KEY) Receives a Buy From RBC Capital
TipRanksDec 24, 2022 09:50
Roth Capital Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $90
Benzinga Real-time NewsDec 23, 2022 20:46
Loop Capital Downgrades Paramount Global to Sell From Hold, Cuts Price Target to $14 From $30
MT NewswiresDec 23, 2022 20:22
No Data
No Data